Issues related to Medicare and Medicaid, specifically drug pricing, reconciliation, TCET, MCED, and coverage generally. Additionally, in health care, issues related to funding and reorganization of NIH and FDA. IP issues to drug and device patents. Trade issues on tariffs.
2025 · 2nd Quarter (Apr 1 - June 30)
CALIFORNIA LIFE SCIENCES
Filed by WILLIAMS AND JENSEN, PLLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration - Amendment
- Posted
- Jun 3, 2025
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- WILLIAMS AND JENSEN, PLLC
- Client
- CALIFORNIA LIFE SCIENCES
- Filing UUID
- 1b074422-7cfa-4e03-a0b4-4c9b9a1a1c87
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicare and Medicaid, specifically drug pricing, reconciliation, TCET, MCED, and coverage generally. Additionally, in health care, issues related to funding and reorganization of NIH and FDA. IP issues to drug and device patents. Trade issues on tariffs.
Issues related to Medicare and Medicaid, specifically drug pricing, reconciliation, TCET, MCED, and coverage generally. Additionally, in health care, issues related to funding and reorganization of NIH and FDA. IP issues to drug and device patents. Trade issues on tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.